Group 1 - The core viewpoint of the articles highlights the performance and valuation of Liaoning Port Co., Ltd., which has a closing price of 1.6 yuan and a rolling PE ratio of 25.17 times, indicating a higher valuation compared to the industry average [1][2] - The company has a total market capitalization of 37.715 billion yuan, ranking 26th in the shipping and port industry, which has an average PE ratio of 18.49 times and a median of 16.78 times [1][2] - As of March 31, 2014, the number of shareholders for Liaoning Port Co., Ltd. was 89,923, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - The company's main business includes oil/liquid chemical product terminals and related logistics, container terminals, automobile terminals, bulk cargo terminals, grain terminals, passenger roll-on/roll-off terminals, and port value-added services [1] - For the third quarter of 2025, the company reported an operating income of 8.426 billion yuan, a year-on-year increase of 5.99%, and a net profit of 1.3 billion yuan, reflecting a year-on-year increase of 37.51% with a sales gross margin of 31.20% [1]

股东方面，截至2019年6月30日，中远海能股东户数90463户，较上次减少10902户，户均持股市值35.28 万元，户均持股数量2.76万股。 交易所数据显示，12月12日，中远海能收盘11.41元，上涨1.51%，滚动市盈率PE（当前股价与前四季度 每股收益总和的比值）达到18.88倍，总市值623.58亿元。 从行业市盈率排名来看，公司所处的航运港口行业市盈率平均18.49倍，行业中值16.78倍，中远海能排 名第22位。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13中远海能18.8815.451.67623.58亿行业平均 18.4918.181.38306.44亿行业中值16.7816.031.25145.41亿1中远海控6.104.731.002320.37亿2上港集团 8.908.580.921282.80亿3锦江航运9.7814.241.59145.33亿4青岛港10.2510.741.24562.13亿5招商港口 10.7510.920.77493.13亿6中远海特11.7912.761.18195.37亿7招商南油12.007.571.27145.50亿8秦港股份 12.0 ...

交易所数据显示，12月12日，华兰股份收盘51.18元，上涨5.35%，滚动市盈率PE（当前股价与前四季度 每股收益总和的比值）达到165.92倍，创947天以来新低，总市值84.04亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均50.65倍，行业中值38.17倍，华兰股份排 名第111位。 截至2025年三季报，共有7家机构持仓华兰股份，其中其他4家、基金2家、保险1家，合计持股数 7117.19万股，持股市值30.26亿元。 江苏华兰药用新材料股份有限公司的主营业务是直接接触注射剂类药品包装材料的研发、生产和销售。 公司的主要产品是覆膜胶塞、常规胶塞、其他。公司被江苏省市场监督管理局、江苏省发展和改革委员 会评为"江苏省质量信用AAA级企业"；被江苏省工业和信息化厅评为"江苏省智能制造示范车间"。 最新一期业绩显示，2025年三季报，公司实现营业收入4.41亿元，同比增加4.36%；净利润5331.60万 元，同比增加2.06%，销售毛利率38.92%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13华兰股份165.92169.523.8784.04亿行业平均 50.6552. ...

交易所数据显示，12月10日，龙源电力收盘15.62元，上涨1.03%，滚动市盈率PE（当前股价与前四季度 每股收益总和的比值）达到25.23倍，总市值1305.80亿元。 从行业市盈率排名来看，公司所处的电力行业行业市盈率平均26.06倍，行业中值21.40倍，龙源电力排 名第52位。 资金流向方面，12月10日，龙源电力主力资金净流入284.22万元，近5日总体呈流入状态，5日共流入 396.09万元。 龙源电力集团股份有限公司的主营业务是风力、光伏发电业务。公司的主要产品是电力产品、热力产 品、煤炭、其他。 最新一期业绩显示，2025年三季报，公司实现营业收入222.21亿元，同比减少17.29%；净利润43.93亿 元，同比减少21.02%，销售毛利率39.11%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13龙源电力25.2320.581.721305.80亿行业平均 26.0623.652.14412.82亿行业中值21.4021.811.57143.38亿1皖能电力7.799.011.08185.88亿2江苏国信 8.319.100.84294.69亿3华能国际8.4312.111 ...

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Baoli International, indicating a significant disparity between its high PE ratio and declining revenue and profit figures [1][2] - As of December 8, Baoli International's closing price was 4.05 CNY, with a PE ratio of 717.94, which is substantially higher than the industry average of 50.30 and median of 41.87 [1][2] - The company's total market capitalization stands at 3.732 billion CNY, ranking it 164th in the chemical products industry based on PE ratio [1][2] Group 2 - Baoli International's main business includes the production and sales of various asphalt products, such as modified asphalt and emulsified asphalt, as well as helicopter and aviation material sales [1] - The latest financial report for Q3 2025 shows a revenue of 1.067 billion CNY, a year-on-year decrease of 36.42%, and a net loss of approximately 10.13 million CNY, representing a 245.22% decline compared to the previous year [1] - The gross profit margin for the company is reported at 1.75%, indicating challenges in maintaining profitability amidst declining sales [1]

北方国际合作股份有限公司的主营业务是工程建设与服务、资源供应链、电力运营、工业制造。公司的 主要产品是工程建设与服务、资源设备供应链、电力运营、工业制造。 最新一期业绩显示，2025年三季报，公司实现营业收入99.15亿元，同比减少29.79%；净利润4.85亿 元，同比减少36.02%，销售毛利率14.24%。 交易所数据显示，12月4日，北方国际收盘12.48元，上涨2.89%，滚动市盈率PE（当前股价与前四季度 每股收益总和的比值）达到17.22倍，总市值133.71亿元。 从行业市盈率排名来看，公司所处的工程建设行业市盈率平均25.16倍，行业中值21.08倍，北方国际排 名第40位。 资金流向方面，12月4日，北方国际主力资金净流入1826.82万元，近5日总体呈流出状态，5日共流出 10293.55万元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13北方国际17.2212.741.31133.71亿行业平均 25.1621.431.49217.24亿行业中值21.0825.561.6774.05亿1山东路桥4.134.040.5993.92亿2中国建筑 4.894.730.45218 ...

Core Viewpoint - The stock of ShenKai Co., Ltd. closed at 11.9 yuan on December 3, with a 4.29% increase, and its rolling PE ratio reached a new low of 90.82 times over the past 14 days, with a total market value of 4.331 billion yuan [1] Company Summary - ShenKai Co., Ltd. specializes in the research, manufacturing, and sales of equipment in the oil exploration, drilling, and refining sectors, with main products including oil and gas drilling equipment, exploration instruments, and petroleum product analysis instruments [1] - For the third quarter of 2025, the company reported an operating income of 568 million yuan, a year-on-year increase of 14.47%, and a net profit of 37.775 million yuan, reflecting an 86.46% increase, with a gross profit margin of 36.40% [1] Industry Summary - The average PE ratio for the specialized equipment industry is 78.43 times, with a median of 60.64 times, positioning ShenKai Co., Ltd. at the 206th rank within the industry [1] - The total market value of the industry averages 7.508 billion yuan, with ShenKai Co., Ltd. having a market value of 4.331 billion yuan [2]

交易所数据显示，11月28日，亚钾国际收盘44.15元，上涨1.01%，滚动市盈率PE（当前股价与前四季度 每股收益总和的比值）达到22.73倍，总市值407.97亿元。 从行业市盈率排名来看，公司所处的化肥行业行业市盈率平均27.87倍，行业中值23.65倍，亚钾国际排 名第15位。 股东方面，截至2025年9月30日，亚钾国际股东户数22729户，较上次减少3806户，户均持股市值35.28 万元，户均持股数量2.76万股。 亚钾国际投资(广州)股份有限公司的主营业务是钾盐矿开采、钾肥生产及销售业务。公司的主要产品是 氯化钾。 最新一期业绩显示，2025年三季报，公司实现营业收入38.67亿元，同比增加55.76%；净利润13.63亿 元，同比增加163.01%，销售毛利率58.91%。 来源：市场资讯 序号股票简称PE(TTM)PE(静)市净率总市值(元)8亚钾国际22.7342.923.12407.97亿行业平均 27.8732.423.29216.32亿行业中值23.6530.012.0781.78亿1云天化10.0110.592.33564.58亿2史丹利 11.1413.181.49108.85 ...

Market Overview - The market experienced a pullback after an initial rise, with mixed performance across the three major indices, resulting in over 2,700 stocks rising in total [1] - The A-share indices showed slight declines, with the CSI 300 and ChiNext indices down by 0.1% and 0.9% respectively, while the Hang Seng China Enterprises Index saw a marginal increase of 0.03% [1] Sector Performance - Sectors such as organic silicon, batteries, and consumer electronics led the gains, while sectors like Hainan, film and television, and AID usage faced declines [1] - The innovative drug sector in the Hong Kong market continued its upward trend, although technology stocks exhibited mixed performance [1] Index Details - The CSI 300 Index, which consists of 300 large-cap stocks from the A-share market, has a rolling P/E ratio of 13.9 times and experienced a slight decline [3] - The CSI A500 Index, covering 500 stocks with good liquidity, has a rolling P/E ratio of 16.4 times and also saw a decrease of 0.1% [3] - The ChiNext Index, which includes 100 large-cap stocks with a high proportion of strategic emerging industries, recorded a gain of 0.4% with a rolling P/E ratio of 39.1 times [3] - The STAR Market 50 Index, focusing on large-cap stocks in the STAR Market, has a rolling P/E ratio of 148.1 times and declined by 0.3% [4] - The Hang Seng China Enterprises Index, which tracks 50 large-cap Chinese companies listed in Hong Kong, maintained a stable performance with a rolling P/E ratio of 10.6 times [4]

宁波天益医疗器械股份有限公司的主营业务是血液净化及病房护理领域医用高分子耗材等医疗器械的研 发、生产与销售。公司的主要产品是血液净化装置的体外循环血路、一次性使用动静脉穿刺器、血液透 析浓缩液/血液透析干粉、一次性使用一体式吸氧管、喂食器及喂液管。 最新一期业绩显示，2025年三季报，公司实现营业收入3.87亿元，同比增加24.14%；净利润2009.41万 元，同比增加216.81%，销售毛利率38.39%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13天益医疗267.24-4672.432.9434.76亿行业平均 51.6852.394.44110.26亿行业中值40.1037.172.7757.10亿1九安医疗10.1811.530.87192.38亿2康德莱 15.5917.651.4238.00亿3英科医疗15.9818.571.50272.09亿4奥美医疗16.1319.791.9672.95亿5维力医疗 16.3018.152.0639.81亿6安杰思17.5716.351.9347.96亿7山东药玻17.6814.341.66135.24亿8新华医疗 17.8813.161.1 ...